We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
36 hedge funds and large institutions have $6.86M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% less funds holding
Funds holding: 49 → 36 (-13)
37% less call options, than puts
Call options by funds: $31K | Put options by funds: $49K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
83% less capital invested
Capital invested by funds: $39.7M → $6.86M (-$32.9M)
Holders
36
Holders Change
-13
Holders Change %
-26.53%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
4
Increased
5
Reduced
10
Closed
16
Calls
$31K
Puts
$49K
Net Calls
-$18K
Net Calls Change
-$137K
Top Buyers
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$5.49M |
| 2 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$3.03M |
| 3 |
Morgan Stanley
New York
|
-$1.84M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.35M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$1.31M |
